Innate Pharma (IPHA) Q3 2026 Earnings

Sep 17Confirmed
Q1 2025
Q3 2025
Q1 2026
Q3 2026
-0.35
-0.31
-0.28
-0.24

Details

Expected EPS
-0.2912253
Actual EPS
-0.2398326
Surprise EPS
0.05
Surprise Percent
+17.65%

Description

⁨Innate Pharma⁩ (⁦IPHA⁩) has reported earnings of ⁦-0.2398326⁩ per share for ⁦Q3 2026⁩.

0 Comments

Share your thoughts